DMIIU Drugs Made In America Acquisition II Corp. - Unit
NASDAQ · N/A · View on SEC EDGAR ↗ close Oct 1, 2026 10-K/10-Q Aug 14, 2026
$10.20
· of 52w range
· above low
· to high
$9.9552w low
$10.8052w high
Market Cap (MRQ)
$140M
your badges
52W Range
$10–$11
Analyst Rating
·
Price Target
·
P/E
·
ROE
-46.6%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
DMIIU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.20
Market Cap (MRQ)
$140M
ROE
-46.6%
Debt/Equity (MRQ)
-0.0
52W Range
$10–$11
DMIIU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DMIIU | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | -7.8 | · | · | · | |
| Price / Cash Flow | -137.2 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DMIIU | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | 1.7% | · | · | · | |
| ROE | -46.6% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DMIIU | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | -0.0 | · | · | · | |
| Current Ratio (MRQ) | 0.3 | · | · | · | |
| Quick Ratio | 0.0 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 |
|---|---|---|
| SG&A Expense | $488.4K | |
| Operating Expenses | $488.4K | |
| Operating Income | $-488.4K | |
| Interest Income | $5M | |
| Other Non-op | $5M | |
| Net Income | $4M | |
| EBITDA | $-488.4K |
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $223 | |
| Prepaid Expense | $25.8K | |
| Current Assets | $26.0K | |
| Total Assets | $505M | |
| Accounts Payable | $99.4K | |
| Accrued Liabilities | $88.3K | |
| Current Liabilities | $300.9K | |
| Total Liabilities | $18M | |
| Common Stock | $1.4K | |
| Retained Earnings | $-18M | |
| Stockholders' Equity | $-18M | |
| Liabilities + Equity | $505M | |
| Shares Outstanding | 13,700,000 |
Cash Flow
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-1M | |
| Investing Cash Flow | $-500M | |
| Financing Cash Flow | $501M |
Profitability
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 1.7% | |
| ROE | -46.6% |
Liquidity & Solvency
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 0.1 | |
| Quick Ratio | 0.0 |
Per Share
| Metric | Trend | 2025 |
|---|---|---|
| Book Value / Share | $-1.30 | |
| Cash / Share | $0.00 |
Valuation (TTM)
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $4M | |
| Market Cap | $137M | |
| P/B | -7.7 | |
| P / Cash Flow | -134.7 |
Income Statement
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| SG&A Expense | $112.2K | $235.5K | $155.5K | $38.1K | |
| Operating Expenses | $112.2K | · | · | $38.1K | |
| Operating Income | $-112.2K | $-235.5K | $-155.5K | $-38.1K | |
| Interest Income | $5M | $5M | $109.4K | · | |
| Other Non-op | $5M | $5M | $109.4K | · | |
| Net Income | $4M | $4M | $-46.2K | $-38.1K | |
| EBITDA | $-112.2K | · | $-155.5K | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $175.0K | $223 | $315.1K | · | |
| Prepaid Expense | $42.8K | $25.8K | $15.0K | · | |
| Current Assets | $217.8K | $26.0K | $896.4K | · | |
| Total Assets | $514M | $505M | $501M | · | |
| Accounts Payable | $12.3K | $99.4K | $4.6K | · | |
| Accrued Liabilities | $69.2K | $88.3K | $5.8K | · | |
| Short-term Debt | $450.0K | · | · | · | |
| Current Liabilities | $644.6K | $300.9K | $677.3K | · | |
| Total Liabilities | $18M | $18M | $18M | · | |
| Total Debt | $450.0K | · | · | · | |
| Common Stock | $1.4K | $1.4K | $1.6K | · | |
| Retained Earnings | $-18M | $-18M | $-17M | · | |
| Stockholders' Equity | $-18M | $-18M | $-17M | · | |
| Liabilities + Equity | $514M | $505M | $501M | · | |
| Shares Outstanding | 13,700,000 | 13,700,000 | 15,575,000 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-172.7K | $-314.9K | $-690.7K | $-2.6K | |
| Investing Cash Flow | · | $0 | · | · | |
| Financing Cash Flow | $0 | $0 | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| ROA | 1.7% | · | -0.02% | · | |
| ROE | -49.0% | · | 0.53% | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Current Ratio | 0.3 | · | 1.3 | · | |
| Quick Ratio | 0.3 | · | 0.5 | · | |
| Debt / Equity | -0.0 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Book Value / Share | $-1.31 | · | $-1.11 | · | |
| Cash / Share | $0.01 | · | $0.02 | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Net Income TTM | $13M | · | · | · | |
| Market Cap | $139M | · | $155M | · | |
| Enterprise Value | $139M | · | · | · | |
| P/B | -7.8 | · | -9.0 | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income | $4M | · |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Current Ratio | 0.1 | · |
| Quick Ratio | 0.0 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 12 filers · $35.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
12
Value held
$35.0M
New positions
0
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (-1 vs prior Q) | 3 (-14 vs prior Q) | 1 (0 vs prior Q) | 3 (-1 vs prior Q) | -907K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| LMR Partners LLP | $20,320,000 | 2,000,000 | 58.08% | Shares |
| Westchester Capital Management, LLC | $5,109,606 | 502,914 | 14.61% | Shares |
| Verition Fund Management LLC | $2,540,000 | 250,000 | 7.26% | Shares |
| BlueCrest Capital Management Ltd | $2,540,000 | 250,000 | 7.26% | Shares |
| Walleye Capital LLC | $1,016,000 | 100,000 | 2.90% | Shares |
| L1 Global Manager Pty Ltd | $1,016,000 | 100,000 | 2.90% | Shares |
| READYSTATE ASSET MANAGEMENT LP | $1,016,000 | 100,000 | 2.90% | Shares |
| Maso Capital Partners Ltd | $994,500 | 100,000 | 2.84% | Shares |
| Rangeley Capital, LLC | $330,718 | 32,551 | 0.95% | Shares |
| Clear Street Group Inc. | $82,133 | 8,084 | 0.23% | Shares |
| UBS Group AG | $17,932 | 1,765 | 0.05% | Shares |
| HRT FINANCIAL LP | $1,013 | 99,725 | 0.00% | Shares |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026